U.S. Banks Stock News

In December 2025, Repligen Corporation launched three new high-performance chromatography resins, AVIPure® HiPer™ AAV9, AVIPure® HiPer™ AAV8, and HiPer™ QA, built on Tantti™ DuloCore™ technology to support advanced bioprocessing and gene therapy applications. By extending its proteins and viral-vector-focused resin portfolio ahead of broader chromatography launches expected in 2026, Repligen is positioning itself as a more integral tools provider for next-generation gene therapy...

Earlier this week, Home Depot reaffirmed its fiscal 2025 guidance and issued a cautious 2026 outlook, pointing to ongoing housing market softness, restrained discretionary project spending, and a modest sales and earnings growth profile while it prioritizes Pro customer relationships and integrates recent acquisitions. The update also flagged a recent security issue involving leaked internal credentials, adding an operational risk angle to an already macro-sensitive business story built...

Pinterest (PINS) has quietly outperformed the market over the past month, climbing about 5%, even as the stock remains well below its highs after a rough past 3 months. See our latest analysis for Pinterest. That rebound sits against a tougher backdrop, with the share price still down sharply on a 90 day basis while the three year total shareholder return remains positive. This suggests longer term believers are not capitulating and momentum may be stabilizing rather than accelerating. If...

Earlier in December 2025, Olema Pharmaceuticals, Inc. was added to the S&P Biotechnology Select Industry Index, expanding its presence among publicly traded biotech peers. This index inclusion can be important because it often boosts a company’s visibility with institutional investors and index-tracking funds that may adjust their holdings accordingly. We’ll now examine how Olema’s inclusion in the S&P Biotechnology Select Industry Index shapes its investment narrative and future investor...

Brown-Forman (BF.B) has quietly slipped this year, with shares down about 28% year to date, even as revenue and net income are still growing. That disconnect is where the story gets interesting. See our latest analysis for Brown-Forman. After a tough run that has left the year to date share price return at around negative 28 percent, the stock now trades at about 26 dollars and 89 cents. This suggests sentiment has faded even as fundamentals keep grinding higher. If this kind of reset has you...

UiPath NYSE:PATH is back in focus after being tapped to join the S&P MidCap 400, a step up that can reshape who owns the stock and how it trades heading into 2026. See our latest analysis for UiPath. The index news caps a strong run, with a 1 month share price return of roughly 29 percent and a 3 month share price return above 40 percent. The 3 year total shareholder return of about 42 percent suggests momentum has been rebuilding after earlier volatility. If UiPath’s surge has you rethinking...

In December 2025, Woodward, Inc. proposed amending its Restated Certificate of Incorporation to remove certain supermajority voting requirements and eliminate cumulative voting in director elections, while reporting GAAP earnings per share of $7.19 on US$3.60 billion in revenue and announcing a US$1.80 billion share repurchase plan. Together with new sales growth targets for 2026 focused on automation and aerospace, these governance and capital allocation moves signal a clearer, more...

ARMOUR Residential REIT recently announced past guidance for a January 2026 monthly cash dividend of US$0.24 per common share and disclosed that its external manager will end a voluntary partial fee waiver after February 1, 2026. At the same time, Stonegate Capital Partners initiated coverage highlighting ARMOUR’s strong interest income growth, lower funding costs, high annualized dividend yield, and discount to book value, drawing fresh attention to the mortgage REIT’s income...

Nu Holdings (NYSE:NU) is back in the spotlight after fresh data underscored just how deeply it has penetrated Brazil’s banking market, and how aggressively it is pursuing full banking licenses across multiple countries. See our latest analysis for Nu Holdings. Those licensing moves are helping to support a strong run in the stock, with Nu Holdings’ share price at $16.74 and a powerful year to date share price return of around 57%. Its three year total shareholder return above 300% shows that...

Recent Performance and What Is Moving the Stock New York Times (NYT) has quietly put together a strong run, with the stock up about 11% over the past month and roughly 23% in the past 3 months. See our latest analysis for New York Times. Zooming out, that recent momentum sits on top of a much stronger backdrop, with New York Times delivering a solid year to date share price return and a standout three year total shareholder return, suggesting investors are steadily pricing in durable digital...

CoreWeave (CRWV) continues to attract attention after another choppy week, with shares down about 2% on the day but still up roughly 22% over the past week, inviting fresh questions around sustainability. See our latest analysis for CoreWeave. That jumpy trading pattern fits a much bigger story, with CoreWeave’s year to date share price return of roughly 97 percent showing strong momentum despite a sharp 90 day share price pullback and today’s close at 78.87 dollars. If you like the growth...

If you are wondering whether Solaris Energy Infrastructure is still worth buying after such a strong run, you are not alone. That is exactly what this breakdown is going to tackle in plain language. The stock has climbed 10.9% over the past week and is up 53.0% year to date, on top of a striking 59.4% gain over the last year and a 424.2% return over three years and 565.1% over five years. This naturally raises questions about how much upside is left versus the risk of a pullback. Those moves...

If you are wondering whether NXP Semiconductors is still attractively priced at around $225, or if the easier gains have already been realized, you are not alone. Many investors are trying to determine what fair value looks like at this level. The stock has quietly added 0.9% over the last week and 17.6% over the past month, and is up 9.2% year to date. This comes on top of longer term gains of 6.5% over 1 year, 57.1% over 3 years, and 54.2% over 5 years, which naturally raises the question...

If you are wondering whether Gilead Sciences is still a smart buy after its big run up, or if the value has already been priced in, you are in the right place to unpack what the market might be missing. Gilead has quietly pushed its share price to about $125.67, with returns of 3.6% over the last week, 0.3% over the past month, and a much stronger 36.8% year to date and 37.5% over the last year, building on a 65.1% three year and 168.8% five year climb. Recent headlines around Gilead have...

If you are wondering whether IMAX is still a smart buy after its big run, or if most of the easy gains are already gone, this breakdown is for you. The stock has climbed to around $37.72, adding 0.8% over the last week, 4.8% over the past month, and 50.2% year to date, with a 49.3% gain over 1 year and 169.4% over 3 years, which points to a strong rerating story. Recent headlines have focused on IMAX's expanding footprint in premium large format theaters globally and a steady pipeline of...

Fluence Energy (FLNC) just saw its share price drop about 22% in a week after analyst downgrades collided with a mixed quarter, softer revenue, record orders, and better margins. See our latest analysis for Fluence Energy. Stepping back, the stock has actually been in a strong upswing, with a 90 day share price return of 69.05% and a 1 year total shareholder return of 22.94%. This latest pullback looks more like momentum cooling than a full reset in expectations. If Fluence’s volatility has...

Recent trading in Constellation Brands (STZ) has been driven by a clash between optimism and caution, as investors digest upbeat Wall Street expectations alongside softer organic growth and an outlook for declining sales in a tougher demand backdrop. See our latest analysis for Constellation Brands. Those crosscurrents help explain why, even with a roughly 6 percent 1 month share price return and recent rebound toward 140.49 dollars, Constellation Brands still shows a deeply negative 1 year...

In December 2025, Akamai Technologies announced ISV Catalyst, a new referral-based partner program to attract independent software vendors to its globally distributed cloud platform, and revealed a collaboration with Visa that integrates Visa’s Trusted Agent Protocol with Akamai’s edge-based security to support identity, authentication, and fraud controls for AI-driven commerce. Together, these initiatives highlight how Akamai is trying to position its cloud and edge infrastructure as a...

Wondering whether Pinnacle Financial Partners at around $101 a share is a bargain or a value trap right now? You are not alone, and that is exactly what we are going to unpack. The stock has climbed 1.1% over the last week and 12.4% over the past month, but it is still down around 10.8% year to date and 10.7% over the last year, despite delivering 44.2% and 65.3% over the past 3 and 5 years respectively. Recent headlines have focused on regional banks balancing tighter funding conditions...

Occidental Petroleum (OXY) has been grinding lower, with shares down about 3% over the past month and roughly 15% in the past 3 months, even as longer term returns remain positive. See our latest analysis for Occidental Petroleum. Zooming out, the 1 year total shareholder return of negative 15 percent and a year to date share price return near negative 20 percent suggest momentum has clearly been fading, even after a strong 5 year total shareholder return. If this pullback has you reassessing...

General Dynamics (GD) has been quietly grinding higher in recent months, and the latest leg of this move has investors asking whether the current valuation still leaves room for further gains. See our latest analysis for General Dynamics. With the share price now around $345.39 and a strong year to date share price return of over 30 percent, momentum looks more like a steady repricing of General Dynamics long term defense and aerospace cash flows than a short lived spike, especially when you...

If you are wondering whether Coca-Cola is still attractive at around $70 a share, or if the easy money has already been made, you are not alone. That is exactly what we are going to unpack here. Despite a recent pullback of 0.8% over the last week and 3.4% over the past month, the stock is still up 13.4% year to date and nearly 50% over five years, which indicates that long term holders have been rewarded. Recent headlines have focused on Coca-Cola expanding its zero sugar lineup and...

Nebius Group (NasdaqGS:NBIS) has been on traders’ screens after unveiling multi year AI infrastructure deals with Microsoft and Meta, alongside its Nebius AI Cloud 3.1 upgrade. Together, these developments reshape its revenue visibility and competitive positioning. See our latest analysis for Nebius Group. The Microsoft and Meta contracts, together with the Nebius AI Cloud 3.1 launch, have reignited interest in Nebius. The stock’s recent 7 day share price return of 20.78% has helped extend a...

In December 2025, Sports Research® announced a major expansion of its premium supplement lineup at Costco®, now supplying 10 products nationwide, while Costco reported first-quarter 2026 revenue of US$67.31 billion and net income of US$2.00 billion, and completed a US$2.25 billion share repurchase program initiated in January 2023. The deeper Sports Research presence in Costco’s tightly curated wellness aisles, combined with Costco’s solid earnings and disciplined capital returns, highlights...